Contact
Please use this form to send email to PR contact of this press release:
Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA
TO:
Please use this form to send email to PR contact of this press release:
Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA
TO: